CARDIFF ONCOLOGY, INC.

Profile

Company Names

CARDIFF ONCOLOGY, INC.
TROVAGENE, INC.
TROVAGENE INC.

Addresses

11055 FLINTKOTE AVENUE, SAN DIEGO, CA 92121

11055 FLINTKOTE AVENUE, SUITE B, SAN DIEGO, CA 92121

Phone Numbers

(858) 952-7570
858-952-7570
858-217-4838
858 217 4838

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$38,752,200.00

Number of Funding Rounds:

11
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
11
2020-06-16 
$13,500,000.00 
$13,500,000.00 
$0.00 
Equity 
10
2020-05-26 
$2,500,000.00 
$2,500,000.00 
$0.00 
Equity 
9
2020-05-12 
$810,000.00 
$810,000.00 
$0.00 
Equity 
8
2020-03-30 
$2,084,000.00 
$2,084,000.00 
$0.00 
Equity 
7
2019-10-30 
$5,000,000.00 
$5,000,000.00 
$0.00 
Equity 
6
2019-08-22 
$1,500,000.00 
$1,500,000.00 
$0.00 
Equity 
5
2019-05-15 
$1,500,000.00 
$1,500,000.00 
$0.00 
Equity 
4
2019-04-05 
$1,500,000.00 
$1,500,000.00 
$0.00 
Equity 
3
2017-07-19 
$0.00 
$6,547,512.00 
$6,547,512.00 
 
2
2012-11-21 
$3,760,000.00 
$4,420,000.00 
$660,000.00 
Equity 
1
2009-06-10 
$6,598,200.00 
$6,598,200.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
THOMAS 
 
ADAMS 
DIRECTOR, EXECUTIVE OFFICER
THOMAS 
H. 
ADAMS 
EXECUTIVE OFFICER, DIRECTOR
THOMAS 
 
ADAMS, PH.D. 
DIRECTOR
JAMES 
 
ARMITAGE 
DIRECTOR
JAMES 
O. 
ARMITAGE 
DIRECTOR
PAUL 
 
BILLINGS 
DIRECTOR
GABRIELE 
 
CERRONE 
DIRECTOR
ATHENA 
 
COUNTOURIOTIS 
DIRECTOR
MARK 
 
ERLANDER 
EXECUTIVE OFFICER, DIRECTOR
MARK 
 
ERLANDER, PH.D. 
EXECUTIVE OFFICER
GARY 
 
JACOB, PH.D. 
DIRECTOR
BRIGITTE 
 
LINDSAY 
EXECUTIVE OFFICER
RODNEY 
 
MARKIN 
DIRECTOR
RODNEY 
S. 
MARKIN 
DIRECTOR
GARY 
W. 
PACE 
DIRECTOR
GARY 
 
PACE, PH.D. 
DIRECTOR
ANTONIUS 
 
SCHUH 
EXECUTIVE OFFICER, DIRECTOR
STANLEY 
 
TENNANT 
DIRECTOR
WILLIAM 
 
WELCH 
EXECUTIVE OFFICER, DIRECTOR
LALE 
 
WHITE 
DIRECTOR
STEVE 
 
ZANIBOBI 
EXECUTIVE OFFICER
STEVE 
 
ZANIBONI 
EXECUTIVE OFFICER
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2020-06-16 
D
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2020-05-26 
D
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2020-05-12 
D
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2020-03-30 
D
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2019-10-30 
D
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2019-08-22 
D
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2019-05-15 
D
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2019-04-05 
D
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
$1 - $1,000,000 
 
2017-07-19 
D
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
$1 - $1,000,000 
Equity 
2012-11-21 
D
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
$1 - $1,000,000 
Equity 
2009-06-10 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
H.C. WAINWRIGHT + CO., LLC
375
NA
NONE
MAXIM GROUP LLC